Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line

Oncology Letters

Volumn 2, Issue 2, 2011, Pages 211-215

  Shinka, Toshiaki ^a   Onodera, Dai ^b   Tanaka, Tetsuji ^a   Shoji, Noriaki ^b   Miyazaki, Tadaaki ^c   Moriuchi, Tetsuya ^c   Fukumoto, Takahiro ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Dopa decarboxylase; Prostate cancer; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AROMATIC LEVO AMINO ACID DECARBOXYLASE; GROWTH FACTOR; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; TRYPTOPHAN HYDROXYLASE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROSECRETORY CELL; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONIN METABOLISM; SYNTHESIS; TUMOR GROWTH;

EID: 79551618559     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.244     Document Type: Article

References (18)

1. Chin SN, Wang L, Moore M and Sridhar SS: A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital. Curr Oncol 17: 24-29, 2010.
2. Sandberg AA: Endocrine control and physiology of the prostate. Prostate 1: 169-184, 1980.
3. Abrahamsson PA: Prostate cancer and active surveillance. Front Radiat Ther Oncol 41: 1-6, 2008.
4. Hansson J and Abrahamsson PA: Neuroendocrine differentiation in prostatic carcinoma. Scand j Urol Nephrol Suppl 212: 28-36, 2003.
5. Seuwen K and Pouyssegur J: Serotonin as a growth factor. Biochem Pharmacol 39: 958-990, 1990.
6. Waguespack SG, Rich T, Grubbs E, Ying Ak, Perrier ND, Ayala-Ramirez M and jimenez C: A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. j Clin Endocrinol Metab 95: 2023-2037, 2010.
7. Rapport MM, Green AA and Page IH: Serum vasoconstrictor (serotonin) IV: Isolation and characterization. j Biol Chem 176: 1243-1251, 1948.
8. Fukumoto T, kema PI and Levin M: Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. Curr Biol 15: 794-803, 2005.
9. Buznikov GA, Lambert HW and Lauder JM: Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res 305: 177-186, 2001.
10. Marino J and Caballero J: IIoperidone for the treatment of schizophrenia. Ann Pharmacother 44: 863-870, 2010.
11. Julius D, Livelli TJ, Jessel TM and Axel R: Ectopic expression of serotonin 1c receptor and triggering of malignant transformation. Science 244: 1057-1062, 1989.
12. Siddiqui EJ, Thompson CS, Mikhailidis DP and Mumtaz FH: The role of serotonin in tumour growth (Review). Oncol Rep 14: 1593-1597, 2005.
13. Feng LR and Maguire-Zeiss KA: Gene therapy in Parkingson's disease: rationale and current status. CNS Drugs 24: 177-192, 2010.
14. Margiotti K, Wafa LA, Cheng H, Novelli G, Nelson CC and Rennie PS: Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells. Mol Cancer 6: 38-50, 2007.
15. Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N and Dougherty DM: L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res 2: 45-60, 2009.
16. Siddiqui EJ, Shabbir M, Mikhailidis DP, Thompson CS and Mumtaz FH: The role of serotonin (5-hydroxytryptamine 1A and 1B) receptors in prostate cancer cell proliferation. J Urol 176: 1648-1653, 2006.
17. Lembeck F: 5-Hydroxytryptamine in a carcinoid tumor. Nature 172: 910-911, 1953.
18. Pearse AG: The diffuse neuroendocrine system and the APUD concept: related 'endocrine' peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands. Med Biol 55: 115-125, 1977.